copper heptapeptide-14 pantothenate est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for this specific ingredient name; no peer‑reviewed reproductive or developmental toxicity data located in the cited sources. Topical copper‑peptide complexes and peptide salts generally have low dermal systemic bioavailability, so exposure from normal cosmetic use is expected to be negligible. Sources checked: ECHA Annex VI (harmonised CLP) = no entry; CIR/SCCS = no safety assessment for this exact ingredient; PubMed = no reproductive/developmental studies found.
Pregnancy-safe products containing copper heptapeptide-14 pantothenate




![Lumene Nordic Ageless [Ajaton] Radiant Youth Night Cream](/_next/image?url=https%3A%2F%2Fpdi97k8lwqqxczuf.public.blob.vercel-storage.com%2Fproducts%2Flumene-nordic-ageless-ajaton-radiant-youth-night-cream-WZm611hAsGAoXs0iZSG0TswUAI7aKd.webp&w=3840&q=75)

Related ingredients
Frequently asked questions
- copper heptapeptide-14 pantothenate est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for this specific ingredient name; no peer‑reviewed reproductive or developmental toxicity data located in the cited sources. Topical copper‑peptide complexes and peptide salts generally have low dermal systemic bioavailability, so exposure from normal cosmetic use is expected to be negligible. Sources checked: ECHA Annex VI (harmonised CLP) = no entry; CIR/SCCS = no safety assessment for this exact ingredient; PubMed = no reproductive/developmental studies found.
- copper heptapeptide-14 pantothenate est-il sûr pendant l'allaitement ?
- No evidence of lactation/breastmilk transfer or reproductive hazard for this specific ingredient in the available regulatory and literature sources. Given the lack of systemic reproductive/toxicological data and expected low dermal absorption of peptide complexes, systemic exposure in lactating persons from cosmetic topical use is expected to be negligible. Sources checked: ECHA Annex VI, CIR, PubMed, CosIng, PubChem.
- copper heptapeptide-14 pantothenate est-il sûr pour la peau de bébé ?
- No infant‑specific toxicity or dermal absorption studies were identified. By default there is no evidence of reproductive or developmental hazard, but infant skin has higher permeability; while adult topical exposure is assessed as negligible, a precautionary modest increase in exposure score (e=1) is applied for 0–3 yr skin due to the immature barrier and higher surface‑area‑to‑weight ratio. No harmonised CLP flags or specific SCCS/CIR guidance for infant use were found.
- Comment VeriMom évalue-t-il copper heptapeptide-14 pantothenate ?
- VeriMom évalue copper heptapeptide-14 pantothenate à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à copper heptapeptide-14 pantothenate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à copper heptapeptide-14 pantothenate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.